251 related articles for article (PubMed ID: 3255656)
21. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
22. [Experiences with desensitization of early spring pollen allergy using 2 tree pollen extracts].
Henzgen M; Wenz W; Strümpfel R
Z Gesamte Inn Med; 1989 Nov; 44(22):691-3. PubMed ID: 2626850
[TBL] [Abstract][Full Text] [Related]
23. Effect of local nasal immunotherapy on nasal blockage in pollen-induced allergic rhinitis of Guinea pigs.
Nabe T; Kubota K; Mizutani N; Fujii M; Terada T; Takenaka H; Kohno S
Allergol Int; 2008 Dec; 57(4):419-27. PubMed ID: 18946238
[TBL] [Abstract][Full Text] [Related]
24. Genetic engineering of pollen allergens for hayfever immunotherapy.
Bhalla PL
Expert Rev Vaccines; 2003 Feb; 2(1):75-84. PubMed ID: 12901599
[TBL] [Abstract][Full Text] [Related]
25. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of sublingual immunotherapy in children.
Bufe A
Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
[No Abstract] [Full Text] [Related]
27. A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever.
Ortolani C; Pastorello EA; Incorvaia C; Ispano M; Farioli L; Zara C; Pravettoni V; Zanussi C
Allergy; 1994 Jan; 49(1):13-21. PubMed ID: 8198235
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children.
Caramia G; Franceschini F; Cimarelli ZA; Ciucchi MS; Gagliardini R; Ruffini E
Allerg Immunol (Paris); 1996 Nov; 28(9):308-10. PubMed ID: 8986246
[TBL] [Abstract][Full Text] [Related]
30. Dose escalation using carbamylated monomeric tree pollen drops is well tolerated in patients with allergic rhinoconjunctivitis and points towards clinical effects.
Raskopf E; Allekotte S; Compalati E; Singh J; Acikel CH; Mösges R
Allergy; 2019 Nov; 74(11):2273-2276. PubMed ID: 31106436
[No Abstract] [Full Text] [Related]
31. Monitoring of different forms of immunotherapy by measuring of grass pollen specific "blocking antibodies".
Maasch HJ; Puttonen E
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):91-100. PubMed ID: 6625591
[No Abstract] [Full Text] [Related]
32. One grass or many? Does allergy distinguish among species?
Kleine-Tebbe J
Drugs Today (Barc); 2008 Dec; 44 Suppl B():65-7. PubMed ID: 19221623
[No Abstract] [Full Text] [Related]
33. [Sublingual specific immunotherapy for rhinoconjunctivitis caused by grass pollens].
Sabbah A; Lesellin J; Hassoun S; Sicard H; André C
Allerg Immunol (Paris); 1993 Jun; 25(6):241-7. PubMed ID: 8357473
[TBL] [Abstract][Full Text] [Related]
34. [Oral immunotherapy in oculorhinitis from Gramineae].
Pacor ML; Biasi D; Carletto A; Maleknia T; Lunardi C
Recenti Prog Med; 1996 Jan; 87(1):4-6. PubMed ID: 8711254
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of efficacy for Japanese cedar pollen-specific immunotherapy by lymphocyte proliferation test].
Imai T; Nohara O; Katayama N; Endo T; Inoue S; Sakaguchi M; Taniguchi Y; Nakagawa T; Saito S
Arerugi; 1996 Nov; 45(11):1172-80. PubMed ID: 8990529
[TBL] [Abstract][Full Text] [Related]
36. Effect of birch pollen-specific immunotherapy on birch pollen-related hazelnut allergy.
van Hoffen E; Peeters KA; van Neerven RJ; van der Tas CW; Zuidmeer L; van Ieperen-van Dijk AG; Bruijnzeel-Koomen CA; Knol EF; van Ree R; Knulst AC
J Allergy Clin Immunol; 2011 Jan; 127(1):100-1, 101.e1-3. PubMed ID: 20933256
[No Abstract] [Full Text] [Related]
37. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis.
Powell RJ; Frew AJ; Corrigan CJ; Durham SR
Allergy; 2007 Nov; 62(11):1335-8. PubMed ID: 17714551
[TBL] [Abstract][Full Text] [Related]
38. New clinical documentation on ALK grass allergen tablet.
Bachert C
Drugs Today (Barc); 2008 Dec; 44 Suppl B():57-60. PubMed ID: 19221621
[No Abstract] [Full Text] [Related]
39. The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis.
Andrews CP; Ratner PH; Ehler BR; Brooks EG; Pollock BH; Ramirez DA; Jacobs RL
Ann Allergy Asthma Immunol; 2013 Jul; 111(1):9-13. PubMed ID: 23806453
[TBL] [Abstract][Full Text] [Related]
40. Allergen-specific immunotherapy with recombinant grass pollen allergens.
Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
